ACORI Summit

Activating Equity in Community Oncology Research

The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.

The Summit's interactive discussions focused around:

  • The importance of expanding access to clinical trials for patients of all background—to ensure the highest quality care
  • Strategies for engaging patients and their caregivers in shared decision-making around trial enrollment
  • Case studies to demonstrate solutions for optimizing accrual and overcoming barriers to trial participation
  • Tools and resources to support care teams, including budget forms, IRB templates, etc.
  • How to incorporate the patient perspective into trial design: insights for trial sponsors   

We look forward to continuing these conversations and taking action that will tie directly into ACORI's three domains of equity, capacity building, and research diffusion. If you were not able to join us live, the ACORI Summit is now available to view on-demand

For more information on this project, please contact the ACCC Provider Education department.

Executive Summary

ACORI Executive SummaryThe ACORI Call to Action Summit’s Executive Summary was developed as an overview of the action items co-developed by the Summit participants for ACCC and oncology programs and practices, as well as other stakeholders. These action items are intended to serve as foundational resources in support of the ACORI stakeholders in their work to improve equity and inclusion in research and diversify clinical trials.

Learn more about the Summit, the developed action items, and more in this comprehensive Executive Summary.
Download Now


In Collaboration With


Our Supporters

abbvie-200x80 amgen-200x80 astrazeneca-200x80 eisai-200x80 genentech-200x80 merck-200x80 sanofi-genzyme-200x80-long

This project is supported by AbbVie, Amgen, AstraZeneca, Eisai, Genentech, Merck and Sanofi.

Twitter Highlights

More from #ACORISummit